You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 81 No. 2, FEBRUARY 1948 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

HYPOPROTHROMBINEMIA

Effect of Transfusions of Blood Fortified by Administration of Vitamin K to Donors

HUGH R. BUTT, M.D.; THOMAS B. MAGATH, M.D.; THOMAS H. SELDON, M.D.

Arch Intern Med. 1948;81(2):131-136.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

HEMORRHAGES resulting from deficiency of prothrombin can in most instances be adequately controlled by the judicious use of vitamin K. However, it was noted early1 that in certain patients with severe hepatic damage the deficiency of prothrombin could not be corrected even with large amounts of vitamin K administered over long periods. It has always been assumed that the ineffectiveness of vitamin K in such patients was the result of an inadequacy of hepatic parenchyma to utilize vitamin K in the production, or activation, of prothrombin. Hemorrhage in these persons is likely, and even repeated transfusions of whole blood often will not prevent a fatal outcome.

Various types of treatment have been employed in such cases, but transfusions of whole blood have been by far the most successful. It is well known that even whole blood seldom is capable of maintaining normal levels of prothrombin much longer than . . . [Full Text PDF of this Article]


Author Affiliations

ROCHESTER, MINN.

From the Division of Medicine (Dr. Butt), the Division of Clinical Laboratories (Dr. Magath) and the Section on Anesthesiology and Intravenous Therapy (Dr. Seldon), Mayo Clinic.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1948 American Medical Association. All Rights Reserved.